SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA

Abstract. Increased VEGF levels in cancer patients may be associated with decreased number of dendritic cells (DCs) and lower DC function. We investigated whether VEGF gene polymorphisms -2578C>A (rs699947) and +936C>T (rs3025039) are associated with efficacy of autologous DC-based imm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu. A. Khochenkova, G. Z. Chkadua, I. V. Samoylenko, T. F. Malivanova, I. N. Mikhailova, L. V. Demidov, E. V. Stepanova
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2014
Materias:
Acceso en línea:https://doaj.org/article/eeb026a56774434f9e4bf5856688d7d3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eeb026a56774434f9e4bf5856688d7d3
record_format dspace
spelling oai:doaj.org-article:eeb026a56774434f9e4bf5856688d7d32021-11-18T08:03:43ZSIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA1563-06252313-741X10.15789/1563-0625-2013-6-563-570https://doaj.org/article/eeb026a56774434f9e4bf5856688d7d32014-07-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/671https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XAbstract. Increased VEGF levels in cancer patients may be associated with decreased number of dendritic cells (DCs) and lower DC function. We investigated whether VEGF gene polymorphisms -2578C>A (rs699947) and +936C>T (rs3025039) are associated with efficacy of autologous DC-based immunotherapy in patients with malignant melanoma. Evaluation of VEGFR-1 and VEGFR-2 expression on mature monocyte-derived DC revealed a decreased VEGFR-1 level (18.9±0.7% on peripheral blood monocytes, as compared to 6.3±0.6% on mature DCs) and non-changed VEGFR-2 expression (13.1±0.4% and 15.9±0.4%, respectively). The АА genotype frequency of -2578C>A (rs699947) polymorphism of VEGF gene was 46.1%. АС heterozygous state was found in 38.5%, and СС, in 15.4% of cases. The VEGF -2578 AC and AA genotypes were directly associated with progression-free survival and efficacy of treatment. The median progression-free survival of patients with -2578 AA and AC genotypes was a significantly longer (8.4 months), as compared with that of patients with CC genotypes (2.7 months), p = 0.002. The established relationship between genotype and efficacy of immunotherapy can be used to develop modern methods for predicting melanoma progression and to personalize immunotherapy including a combination with antiangiogenic therapy.Yu. A. KhochenkovaG. Z. ChkaduaI. V. SamoylenkoT. F. MalivanovaI. N. MikhailovaL. V. DemidovE. V. StepanovaSPb RAACIarticlevegfsnpsdendritic cellsanticancer immunotherapymetastatic melanomaImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 15, Iss 6, Pp 563-570 (2014)
institution DOAJ
collection DOAJ
language RU
topic vegf
snps
dendritic cells
anticancer immunotherapy
metastatic melanoma
Immunologic diseases. Allergy
RC581-607
spellingShingle vegf
snps
dendritic cells
anticancer immunotherapy
metastatic melanoma
Immunologic diseases. Allergy
RC581-607
Yu. A. Khochenkova
G. Z. Chkadua
I. V. Samoylenko
T. F. Malivanova
I. N. Mikhailova
L. V. Demidov
E. V. Stepanova
SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
description Abstract. Increased VEGF levels in cancer patients may be associated with decreased number of dendritic cells (DCs) and lower DC function. We investigated whether VEGF gene polymorphisms -2578C>A (rs699947) and +936C>T (rs3025039) are associated with efficacy of autologous DC-based immunotherapy in patients with malignant melanoma. Evaluation of VEGFR-1 and VEGFR-2 expression on mature monocyte-derived DC revealed a decreased VEGFR-1 level (18.9±0.7% on peripheral blood monocytes, as compared to 6.3±0.6% on mature DCs) and non-changed VEGFR-2 expression (13.1±0.4% and 15.9±0.4%, respectively). The АА genotype frequency of -2578C>A (rs699947) polymorphism of VEGF gene was 46.1%. АС heterozygous state was found in 38.5%, and СС, in 15.4% of cases. The VEGF -2578 AC and AA genotypes were directly associated with progression-free survival and efficacy of treatment. The median progression-free survival of patients with -2578 AA and AC genotypes was a significantly longer (8.4 months), as compared with that of patients with CC genotypes (2.7 months), p = 0.002. The established relationship between genotype and efficacy of immunotherapy can be used to develop modern methods for predicting melanoma progression and to personalize immunotherapy including a combination with antiangiogenic therapy.
format article
author Yu. A. Khochenkova
G. Z. Chkadua
I. V. Samoylenko
T. F. Malivanova
I. N. Mikhailova
L. V. Demidov
E. V. Stepanova
author_facet Yu. A. Khochenkova
G. Z. Chkadua
I. V. Samoylenko
T. F. Malivanova
I. N. Mikhailova
L. V. Demidov
E. V. Stepanova
author_sort Yu. A. Khochenkova
title SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_short SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_full SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_fullStr SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_full_unstemmed SIGNIFICANCE OF SINGLE-NUCLEOTIDE POLYMORPHISMS 2578C>A AND +936C>T IN THE VEGF GENE FOR EFFICIENCY EVALUAT ION OF ANTICANCER IMMUNOTHERAPY IN PAT IENTS WITH METASTAT IC SKIN MELANOMA
title_sort significance of single-nucleotide polymorphisms 2578c>a and +936c>t in the vegf gene for efficiency evaluat ion of anticancer immunotherapy in pat ients with metastat ic skin melanoma
publisher SPb RAACI
publishDate 2014
url https://doaj.org/article/eeb026a56774434f9e4bf5856688d7d3
work_keys_str_mv AT yuakhochenkova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT gzchkadua significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT ivsamoylenko significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT tfmalivanova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT inmikhailova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT lvdemidov significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
AT evstepanova significanceofsinglenucleotidepolymorphisms2578caand936ctinthevegfgeneforefficiencyevaluationofanticancerimmunotherapyinpatientswithmetastaticskinmelanoma
_version_ 1718422455142318080